APOE Genotype and Cognitive Change in Young, Middle-Aged, and Older Adults Living in the Community
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
We examined whether the apolipoprotein E (APOE) ε4 allele was associated with cognitive benefits in young adulthood and whether it reversed to confer cognitive deficits in later life ("antagonistic pleiotropy") in the absence of dementia-related neuropathology. We also tested whether the ε2 allele was associated with disadvantages in early adulthood but offered protection against cognitive decline in early old age. Eight-year cognitive change was assessed in 2,013 cognitively normal community-dwelling adults aged 20-24, 40-44, or 60-64 years at baseline. Although cognitive decline was associated with age, multilevel models contrasting the ε2 and ε4 alleles provided no evidence that the APOE genotype was related to cognitive change in any of the age groups. The findings suggest that in the absence of clinically salient dementia pathology, APOE ε2 and ε4 alleles do not exhibit antagonistic pleiotropy in relation to cognition between the ages of 20 and 72 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 1×
“In old age, the protective effect of the ɛ2 allele is widely recognized (eg, reference [2]).”
BackgroundProdromal Alzheimer's disease: successive emergence of the clinical symptoms
Amieva, H., Le Goff, M., Millet, X., Orgogozo, J. M., Pérès, K., Barberger‐Gateau, P., Jacqmin‐Gadda, H., & Dartigues, J. F. (2008) · Annals of Neurology · doi:10.1002/ana.21509 · Cited by 737
Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., Baxter, L. C., Rapcsak, S. Z., Shi, J., Woodruff, B. K., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809437 · Cited by 528 · cited 1×
“As possession of the ɛ4 allele is a major risk factor for dementia, it is possible that the ɛ4-related cognitive decline commonly reported (eg, references [10–15]) is associated with the subclinical phase of the disease, even though some studies (eg, references [13,15]) removed persons with low global cognition scores.”
ResultApolipoprotein E and Cognitive Performance: A Meta-Analysis.
Small, B. J., Rosnick, C. B., Fratiglioni, L., & Bäckman, L. (2004) · Psychology and Aging · doi:10.1037/0882-7974.19.4.592 · Cited by 447
Cohort Profile: The PATH through life project
Anstey, K. J., Christensen, H., Butterworth, P., Easteal, S., Mackinnon, A., Jacomb, T., Maxwell, K., Rodgers, B., Windsor, T., Cherbuin, N., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr025 · Cited by 238
Self-citationBondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., & Thal, L. J. (1999) · Psychology and Aging · doi:10.1037//0882-7974.14.2.295 · Cited by 235
Ghebremedhin, E., Schultz, C., Braak, E., & Braak, H. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6860 · Cited by 133
Cited by
Spatial navigation deficits — overlooked cognitive marker for preclinical Alzheimer disease?
Coughlan, G., Laczó, J., Hort, J., Minihane, A.-M., & Hornberger, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0031-x · Cited by 500
Davies, G., Armstrong, N., Bis, J. C., Bressler, J., Chouraki, V, Giddaluru, S., Hofer, E., Ibrahim-Verbaas, C. A., Kirin, M., Lahti, J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.188 · Cited by 384
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Li, Z., Shue, F., Zhao, N., Shinohara, M., & Bu, G. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00413-4 · Cited by 306
Predictors of ageing-related decline across multiple cognitive functions
Ritchie, S. J., Tucker-Drob, E. M., Cox, S. R., Corley, J., Dykiert, D., Redmond, P., Pattie, A., Taylor, A. M., Sibbett, R., Starr, J. M., et al. (2016) · Intelligence · doi:10.1016/j.intell.2016.08.007 · Cited by 147
“First, since it has been suggested that effects of APOE e4 on cognitive decline may be due only to dementia pathology (Bunce et al., 2014), we removed individuals with possible dementia in two differentways (using a dementia screening instrument [Folstein et al., 1975] and using dementia…”
MethodApolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course
Rawle, M. J., Davis, D., Bendayan, R., Wong, A., Kuh, D., & Richards, M. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0064-8 · Cited by 137
Metadata
- Authors
- Bunce, D., Bielak, A. A. M., Anstey, K. J., Cherbuin, N., Batterham, P. J., & Easteal, S.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-31
- Volume
- 69
- Issue
- 4
- Pages
- 379-386
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- OpenAlex
- W2162648764
- Cited by
- 63
- References
- 7
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: APOE Genotype and Cognitive Change in Young, Middle-Aged, and Older Adults Living in the Community. https://app.cochat.ai/papers/10.1093/gerona/glt103
- The paper
- Bunce, D., Bielak, A. A. M., Anstey, K. J., Cherbuin, N., Batterham, P. J., & Easteal, S. (2014). APOE Genotype and Cognitive Change in Young, Middle-Aged, and Older Adults Living in the Community. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glt103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.